Equine interferons following exposure to equid herpesvirus-1 or -4.
- Journal Article
Summary
This research study investigates the response of equine interferon (IFN), an important type of anti-viral protein, in ponies after exposure to two types of herpesviruses – EHV-1 and EHV-4. It finds that the presence and level of IFN in the nasal fluid and blood serum of the infected ponies are linked to virus shedding and clinical symptoms respectively.
Defining Key Terms
- Equine interferons (EqIFN): These are proteins produced by the immune system of horses in response to viral infections. They act as an important defense mechanism by interfering with virus replication.
- EHV-1 and EHV-4: These are types of equid herpesviruses, which cause different respiratory and neurological diseases in equines (horses, donkeys, etc.)
- Viral excretion: This refers to the process where viruses are expelled from the body, usually through bodily fluids.
- Locomotor disorder: This refers to issues with the animal’s ability to move due to problems in the nervous system.
Study Overview
The researchers infected 23 ponies with EHV-1 or EHV-4 and monitored the IFN response in various parts of their bodies:
- The researchers found a direct correlation between the duration of viral excretion and the presence of IFN in nasal fluids. This means that IFN could potentially be used as an indicator of how long a pony will continue to shed the virus and remain infectious.
- IFN was only found in the serum (the clear fluid part of the blood) of ponies who had been infected with EHV-1, not EHV-4. Moreover, the levels of IFN in the serum were directly related to the severity of locomotor disorders. High IFN levels indicated poor prognosis, meaning that the disease was likely to progress more severely.
- Low levels of IFN were also detected in mononuclear cells (a type of white blood cell) from ponies infected with either virus. While the study does not delve deeply into this, it suggests that EHV-1 and EHV-4 may stimulate an IFN response not just in the immediate area of infection but throughout the body’s immune system.
Implications of the Study
The study provides useful insights into the immune response of ponies to herpesvirus infections. Understanding how IFN responds to the presence of EHV-1 or EHV-4 can help veterinarians better predict the course of the disease and plan treatment accordingly. Specifically, the correlation between IFN levels and the severity of symptoms may suggest new ways to diagnose and monitor disease progression. This research could also lead to the development of targeted treatments that modulate the IFN response to fight these infections.
Cite This Article
Publication
Researcher Affiliations
- Department of Veterinary Pathology, Royal Veterinary College, University of London.
MeSH Terms
- Animals
- Female
- Herpesviridae Infections / immunology
- Herpesviridae Infections / veterinary
- Herpesvirus 1, Equid
- Horse Diseases / immunology
- Horse Diseases / microbiology
- Horses
- Interferons / biosynthesis
- Viremia / immunology
- Viremia / veterinary
Citations
This article has been cited 7 times.- Laval K, Poelaert KCK, Van Cleemput J, Zhao J, Vandekerckhove AP, Gryspeerdt AC, Garré B, van der Meulen K, Baghi HB, Dubale HN, Zarak I, Van Crombrugge E, Nauwynck HJ. The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1.. Front Microbiol 2021;12:662686.
- Oladunni FS, Sarkar S, Reedy S, Balasuriya UBR, Horohov DW, Chambers TM. Equid Herpesvirus 1 Targets the Sensitization and Induction Steps To Inhibit the Type I Interferon Response in Equine Endothelial Cells.. J Virol 2019 Dec 1;93(23).
- Poelaert KCK, Van Cleemput J, Laval K, Favoreel HW, Soboll Hussey G, Maes RK, Nauwynck HJ. Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense.. Front Cell Infect Microbiol 2018;8:312.
- Schnabel CL, Wimer CL, Perkins G, Babasyan S, Freer H, Watts C, Rollins A, Osterrieder N, Wagner B. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.. BMC Vet Res 2018 Aug 22;14(1):245.
- Detournay O, Morrison DA, Wagner B, Zarnegar B, Wattrang E. Genomic analysis and mRNA expression of equine type I interferon genes.. J Interferon Cytokine Res 2013 Dec;33(12):746-59.
- Smith D, Hamblin A, Edington N. Equid herpesvirus 1 infection of endothelial cells requires activation of putative adhesion molecules: an in vitro model.. Clin Exp Immunol 2002 Aug;129(2):281-7.
- Charan S, Palmer K, Chester P, Mire-Sluis AR, Meager A, Edington N. Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse.. Immunology 1997 Apr;90(4):586-91.